vs

Side-by-side financial comparison of SOLENO THERAPEUTICS INC (SLNO) and SECURITY NATIONAL FINANCIAL CORP (SNFCA). Click either name above to swap in a different company.

SECURITY NATIONAL FINANCIAL CORP is the larger business by last-quarter revenue ($83.0M vs $66.0M, roughly 1.3× SOLENO THERAPEUTICS INC). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs 16.3%, a 23.1% gap on every dollar of revenue. SECURITY NATIONAL FINANCIAL CORP produced more free cash flow last quarter ($43.8M vs $43.5M).

SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.

CNO Financial Group, Inc., formerly Conseco, Inc., is an American financial services holding company based in Carmel, Indiana. Its insurance subsidiaries provide life insurance, annuity and supplemental health insurance products to more than four million customers in the United States. These products are distributed through independent agents, career agents and direct to customers through television advertising and direct mail.

SLNO vs SNFCA — Head-to-Head

Bigger by revenue
SNFCA
SNFCA
1.3× larger
SNFCA
$83.0M
$66.0M
SLNO
Higher net margin
SLNO
SLNO
23.1% more per $
SLNO
39.4%
16.3%
SNFCA
More free cash flow
SNFCA
SNFCA
$395.6K more FCF
SNFCA
$43.8M
$43.5M
SLNO

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
SLNO
SLNO
SNFCA
SNFCA
Revenue
$66.0M
$83.0M
Net Profit
$26.0M
$13.5M
Gross Margin
98.3%
98.6%
Operating Margin
33.5%
20.9%
Net Margin
39.4%
16.3%
Revenue YoY
4.7%
Net Profit YoY
134.0%
430.9%
EPS (diluted)
$0.47
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SLNO
SLNO
SNFCA
SNFCA
Q4 25
$83.0M
Q3 25
$66.0M
$89.3M
Q2 25
$32.7M
$89.5M
Q1 25
$82.7M
Q4 24
$79.3M
Q3 24
$88.3M
Q2 24
$85.8M
Q1 24
$81.2M
Net Profit
SLNO
SLNO
SNFCA
SNFCA
Q4 25
$13.5M
Q3 25
$26.0M
$7.8M
Q2 25
$-4.7M
$6.5M
Q1 25
$4.3M
Q4 24
$2.5M
Q3 24
$11.8M
Q2 24
$7.3M
Q1 24
$7.5M
Gross Margin
SLNO
SLNO
SNFCA
SNFCA
Q4 25
98.6%
Q3 25
98.3%
98.8%
Q2 25
97.9%
98.7%
Q1 25
98.5%
Q4 24
98.5%
Q3 24
98.7%
Q2 24
98.6%
Q1 24
98.4%
Operating Margin
SLNO
SLNO
SNFCA
SNFCA
Q4 25
20.9%
Q3 25
33.5%
11.4%
Q2 25
-20.0%
9.3%
Q1 25
6.7%
Q4 24
4.0%
Q3 24
17.2%
Q2 24
10.9%
Q1 24
11.8%
Net Margin
SLNO
SLNO
SNFCA
SNFCA
Q4 25
16.3%
Q3 25
39.4%
8.7%
Q2 25
-14.4%
7.3%
Q1 25
5.2%
Q4 24
3.2%
Q3 24
13.4%
Q2 24
8.5%
Q1 24
9.2%
EPS (diluted)
SLNO
SLNO
SNFCA
SNFCA
Q4 25
$0.52
Q3 25
$0.47
$0.31
Q2 25
$-0.09
$0.25
Q1 25
$0.18
Q4 24
$0.09
Q3 24
$0.47
Q2 24
$0.29
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SLNO
SLNO
SNFCA
SNFCA
Cash + ST InvestmentsLiquidity on hand
$498.9M
$102.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$494.8M
$410.4M
Total Assets
$599.9M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SLNO
SLNO
SNFCA
SNFCA
Q4 25
$102.3M
Q3 25
$498.9M
$100.4M
Q2 25
$286.8M
$79.3M
Q1 25
$132.9M
Q4 24
$140.5M
Q3 24
$170.7M
Q2 24
$143.6M
Q1 24
$150.9M
Stockholders' Equity
SLNO
SLNO
SNFCA
SNFCA
Q4 25
$410.4M
Q3 25
$494.8M
$365.4M
Q2 25
$240.1M
$354.8M
Q1 25
$346.5M
Q4 24
$381.9M
Q3 24
$346.3M
Q2 24
$325.8M
Q1 24
$320.1M
Total Assets
SLNO
SLNO
SNFCA
SNFCA
Q4 25
$1.6B
Q3 25
$599.9M
$1.6B
Q2 25
$332.3M
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SLNO
SLNO
SNFCA
SNFCA
Operating Cash FlowLast quarter
$43.5M
$45.5M
Free Cash FlowOCF − Capex
$43.5M
$43.8M
FCF MarginFCF / Revenue
65.8%
52.8%
Capex IntensityCapex / Revenue
0.0%
2.0%
Cash ConversionOCF / Net Profit
1.67×
3.38×
TTM Free Cash FlowTrailing 4 quarters
$69.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SLNO
SLNO
SNFCA
SNFCA
Q4 25
$45.5M
Q3 25
$43.5M
$25.6M
Q2 25
$-12.6M
$-7.7M
Q1 25
$9.6M
Q4 24
$57.3M
Q3 24
$26.8M
Q2 24
$-17.0M
Q1 24
$25.1M
Free Cash Flow
SLNO
SLNO
SNFCA
SNFCA
Q4 25
$43.8M
Q3 25
$43.5M
$24.9M
Q2 25
$-12.6M
$-8.1M
Q1 25
$9.1M
Q4 24
$54.8M
Q3 24
$26.6M
Q2 24
$-17.1M
Q1 24
$24.8M
FCF Margin
SLNO
SLNO
SNFCA
SNFCA
Q4 25
52.8%
Q3 25
65.8%
27.9%
Q2 25
-38.6%
-9.1%
Q1 25
11.1%
Q4 24
69.2%
Q3 24
30.2%
Q2 24
-20.0%
Q1 24
30.6%
Capex Intensity
SLNO
SLNO
SNFCA
SNFCA
Q4 25
2.0%
Q3 25
0.0%
0.8%
Q2 25
0.0%
0.5%
Q1 25
0.5%
Q4 24
3.1%
Q3 24
0.2%
Q2 24
0.2%
Q1 24
0.3%
Cash Conversion
SLNO
SLNO
SNFCA
SNFCA
Q4 25
3.38×
Q3 25
1.67×
3.28×
Q2 25
-1.18×
Q1 25
2.21×
Q4 24
22.55×
Q3 24
2.26×
Q2 24
-2.33×
Q1 24
3.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SLNO
SLNO

Segment breakdown not available.

SNFCA
SNFCA

Life Insurance$29.9M36%
Mortgage$24.8M30%
Other$21.3M26%
Timing Of Revenue Recognition Goods Transferred At A Point In Time$4.6M6%
Timing Of Revenue Recognition Services Transferred At A Point In Time$2.4M3%

Related Comparisons